Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome
Status:
Terminated
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die.
PURPOSE: This phase II trial is studying temozolomide to see how well it works in treating
patients with mycosis fungoides or Sezary syndrome that has not responded to previous
treatment.